 Group Highlights
“ 2 0 0 7 w a sa n o t h e r o u t s t a n d i n gy e a r f o rO p t o s p l cw i t hr e v e n u e
up by 28% on the year to $86.8 million, 28% growth in our
totalinstalledbaseto3,367medicaldevicesandacontinuing
strong rate of contract renewals at 89% for the year.”
Dr John M. Padfield, Chairman 
28%
increase in global revenue to
$86.8 million
52%
increase in operating profit before
share-based payments
$ 1.6m
profit before tax versus
a loss of $1.1 million in 2006
Continued Financial Growth
28% growth in revenue to $86.8m
52% growth in operating profit before share-based 
payments to $9.8m
$1.6 million full year profit before tax versus a loss 
of $1.1 million in 2006
Rapid Geographical Expansion
27% growth in North American revenues
57% growth in European revenues
28% increase in devices installed worldwide to 3,367 
Robust Business Model
90% of revenue on pay-per-patient business model
97% of customers delivering the optomap® Retinal 
Exam through recurring revenue contracts
89% contract renewal rate
Major Investment in Future Growth 
23% increase in average headcount 
19% increase in customer-facing field staff
67% increase in R&D investment
>
>
>
>
>
>
>
>
>
>
>
>
  
Year ended Year ended Year ended
$m 30 Sep 2005  30 Sep 2006  30 Sep 2007
Revenue 48.4 67.7 86.8
Operating profit before share-based payments 4.5 6.5 9.8
Operating profit after share-based payments 3.3 4.3 6.5
(Loss)/profit before tax (2.6) (1.1) 1.6
Financial Profile
2005 2006 2007
48.4
4.5
3.3
-2.6
6.5
4.3
-1.1
9.8
6.5
1.6
67.7
86.8
Optos plc Annual Report & Accounts 2007 1
